In a previous study, we showed that the therapy targeting experimentally induced lung melanoma in mice with IL-15-encoding MYXV construct (vMyx-IL15Rα-tdTr) delivered by MSCs was effective and was able to reduce the tumor burden as well as triggering the inflow of CD8+ cells [33]. The gene discussed is IL15; the disease is neoplasm.